Description: The American Academy of Actuaries and the Society of Actuaries have joined resources to maintain this Economic Scenario Generators Excel Workbook tool for use in regulatory reserve and capital calculations. Please see the SOA website research pages for further information on this tool and how to use it.

Description: The SOA announces the evolution of the Fellowship of the SOA (FSA) pathway. The SOA is making enhancements to help meet the growing global demand for actuarial talent. These enhancements will improve the candidate learning experience and provide more flexibility and global relevancy in the curriculum while maintaining the rigor that has earned respect for the FSA designation worldwide.

Description: Archive of the fall 2013 updates for Group and Health Advanced exam.

Description: This is the disclaimer for the Economic Scenario Generators tool available from the SOA / AAA on the SOA Website.

Description: Quantify the impact on health care costs of specialty drugs and evaluate scenarios for future emerging specialty drugs.

Description: The June 2021 Supreme Court ruling in California vs. Texas has significant ramifications on Affordable Care Act markets. This session will provide the actuarial community an overview of the ruling, the likely impact on health insurance markets, and potential legislation to address the ruling details.

Description: This session will kick off the key National Association of Insurance Commissioners (NAIC) activities, with a primary focus on updates to principle-based reserve valuations and appointed actuary topics. The presenters will provide insights into the current set of activities and initiatives being considered by the NAIC Life Actuarial Task Force (LATF) and Life Risk-Based Capital Working Group, as well as activities being undertaken by American Academy of Actuaries committees and work groups.

Description:

Description: The Tidbit discuss a Revenue Ruling IRS issued to update its position on sales of Life Insurance Contracts

Description: The COVID-19 pandemic has had an impact on all aspects of daily life and its impact extends to how disability incidence may play out in the future. Product profitability will be shaped by how morbidity patterns, interest rate levels and other key drivers will play out into the future. In this session, our panel will discuss COVID’s impact on IDI morbidity experience as observed over the past 18 months, offer comparisons and insights in light of other insurance lines of business, and share emerging information on the on-going effects of Long COVID. Highlights will also include how regional differences and implications for insurers as the industry moves further into the COVID vaccine era.